CD163 and breast carcinoma: Furthermore, we also determined the prognostic significance of CSF-1R+ tumor-associated macrophages and their association with lymphocytic infiltrates expressing immune checkpoint and CD163+ M2 macrophage biomarkers in the context of ER+ breast cancers.